Treatment of Uterine Papillary Serous Carcinoma with Paclitaxel
- 1 July 2001
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 82 (1) , 156-161
- https://doi.org/10.1006/gyno.2001.6211
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Uterine Papillary Serous Carcinoma Treated with Intraperitoneal Cisplatin and Intravenous Doxorubicin and CyclophosphamideGynecologic Oncology, 1996
- Uterine Papillary Serous Carcinoma (UPSC): A Clinicopathologic Study of 30 CasesGynecologic Oncology, 1995
- Uterine papillary serous carcinoma. A clinical studyCancer, 1995
- Histologic Characterization of Uterine Papillary Serous AdenocarcinomaGynecologic Oncology, 1995
- Uterine Papillary Serous Carcinoma: Patterns of Metastatic SpreadGynecologic Oncology, 1994
- Intravenous Cisplatin, Doxorubicin, and Cyclophosphamide in the Treatment of Uterine Papillary Serous Carcinoma (UPSC)Gynecologic Oncology, 1993
- A New Aggressive Treatment Approach to High-Grade Endometrial Cancer of Possible Benefit to Patients with Stage I Uterine Papillary CancerGynecologic Oncology, 1993
- Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)Gynecologic Oncology, 1992
- Malignant papillary lesions of the endometriumGynecologic Oncology, 1987
- Uterine papillary serous carcinomaThe American Journal of Surgical Pathology, 1982